Khaled Alayed

Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients

Sanam Loghavi, Khaled Alayed, Tariq N. Aladily et al. · Journal of Hematology & Oncology · 2015 · 139 citations · Full text

Medicine, Oncology, Pathology +17

<i>TET2</i> mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow

Khaled Alayed, Keyur P. Patel, Sergej Konoplev et al. · American Journal of Hematology · 2013 · 139 citations · Full text

Medicine, Hematology, Pathology +16

BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases

Khaled Alayed, L. Jeffrey Medeiros, Keyur P. Patel et al. · Human Pathology · 2016 · 98 citations

Medicine, Genetics, Pathology +10

Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations

Sergio Piña‐Oviedo, L. Jeffrey Medeiros, Shaoying Li et al. · Modern Pathology · 2017 · 33 citations · Full text

Medicine, Oncology, Pathology +13

CD105 (Endoglin) Is Highly Overexpressed in a Subset of Cases of Acute Myeloid Leukemias

Zaher Chakhachiro, Zhuang Zuo, Tariq N. Aladily et al. · American Journal of Clinical Pathology · 2013 · 21 citations · Full text

Medicine, Hematology, Pathology +9